1
Total Mentions
1
Documents
0
Connected Entities
Organization referenced in documents
HOUSE_OVERSIGHT_024003_sub_001 - HOUSE_OVERSIGHT_024102
rtfolio management responsibilities for NLV-I and NLV-II. Jim is currently on the boards of directors of Chimerix (NASDAQ: CMRX, former Chairman) and Tioga. He was previously on the boards of Intarcia Therapuetics (now currently a Board observer), Sirna Therapeutics (NASDAQ: RNAI, acquired by Merck in 20
No connected entities